Tricuspid valve replacement and levosimendan

[1]  Z. Iscan,et al.  What to expect after tricuspid valve replacement? Long-term results. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  M. Westphal,et al.  Dear levosimendan, the right ventricle will thank you! , 2007, Critical care medicine.

[3]  M. Singer,et al.  Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. , 2006, British journal of anaesthesia.

[4]  W. Toller,et al.  Levosimendan, a New Inotropic and Vasodilator Agent , 2006, Anesthesiology.

[5]  R. Morais.  Levosimendan in severe right ventricular failure following mitral valve replacement. , 2006, Journal of cardiothoracic and vascular anesthesia.

[6]  L. Cohn,et al.  Long-term outcomes of tricuspid valve replacement in the current era. , 2005, The Annals of thoracic surgery.

[7]  C. Polanczyk,et al.  Outcome following isolated tricuspid valve replacement. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  M. Sunagawa,et al.  Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes. , 1997, European journal of pharmacology.

[9]  C. Armstrong,et al.  Tricuspid valve replacement. Fifteen years of experience with mechanical prostheses and bioprostheses. , 1995, The Journal of thoracic and cardiovascular surgery.

[10]  F. Delahaye,et al.  Long-term results of porcine bioprostheses in the tricuspid position. , 1992, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.